Go Pro

Cabaletta Bio (CABA) Earnings Date, Estimates & Call Transcripts

Cabaletta Bio logo
$2.89 +0.14 (+5.09%)
Closing price 08/17/2026 04:00 PM Eastern
Extended Trading
$2.83 -0.06 (-2.08%)
As of 08:10 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cabaletta Bio Earnings Summary

Cabaletta Bio posted Q2 2026 earnings on August 13, 2026, reporting an EPS of -$0.34, which beat analysts' consensus estimates of -$0.37 by $0.03. With a trailing EPS of -$1.57, Cabaletta Bio's earnings are expected to grow next year, from ($1.34) to ($1.12) per share.

Latest Q2
Earnings Date
Aug. 13Estimated
Consensus EPS
(Aug. 13)
-$0.37
Actual EPS
(Aug. 13)
-$0.34 Beat By $0.03

Q2 2026 Earnings Resources

Get Cabaletta Bio Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cabaletta Bio and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

CABA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Cabaletta Bio Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$0.45-$0.39-$0.42
Q2 20262-$0.48-$0.40-$0.44
Q3 20262-$0.49-$0.31-$0.40
Q4 20262-$0.50-$0.31-$0.41
FY 2026 8 -$1.92 -$1.41 -$1.67
Q1 20271-$0.31-$0.31-$0.31
Q2 20271-$0.31-$0.31-$0.31
Q3 20271-$0.33-$0.33-$0.33
Q4 20271-$0.33-$0.33-$0.33

Cabaletta Bio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026-$0.3729-$0.34+$0.0329-$0.34$1.67M-
5/14/2026Q1 2026-$0.41-$0.39+$0.02-$0.39$1.67M-
3/23/2026Q4 2025-$0.45-$0.40+$0.05-$0.40--
11/10/2025Q3 2025-$0.49-$0.44+$0.05-$0.44--
8/7/2025Q2 2025-$0.71-$0.73 -$0.02-$0.73$4.17M-
5/21/2025Q1 2025-$0.67-$0.71 -$0.04-$0.71--
3/31/2025Q4 2024-$0.65-$0.65--$0.65--

Cabaletta Bio Earnings - Frequently Asked Questions

Cabaletta Bio (NASDAQ:CABA) last announced its quarterly earning data on Thursday, August 13, 2026. Learn more on CABA's earnings history.

In the previous quarter, Cabaletta Bio (NASDAQ:CABA) reported ($0.34) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.37) by $0.03. Learn more on analysts' earnings estimate vs. CABA's actual earnings.

Cabaletta Bio's earnings report can be found in their filing with the SEC.
View SEC filing

Cabaletta Bio (NASDAQ:CABA) has a recorded net income of -$167.86 million. CABA has generated -$1.57 earnings per share over the last four quarters.

Cabaletta Bio's earnings are expected to grow from ($1.34) per share to ($1.12) per share in the next year.


Earnings data for NASDAQ:CABA is sourced from Fiscal.ai, with the most recent quarter reported on 8/13/2026. New results are added as companies report their earnings.
From Our Partners